Bellevue, Washington Clinical Trials

*Healthy Children Studies

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Alzheimer's Disease

Northwest Clinical Research Center

A randomized, double-blind, placebo-controlled, twocohort parallel group study to evaluate the efficacy of CAD1 06 and CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer's disease

Northwest Clinical Research Center

A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF GANTENRUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE

Northwest Clinical Research Center

A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects with Dementia of the Alzheimer’s Type

Anemia

Research Site

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Atrial Fibrillation

Overlake Hospital Medical Center

Patients are needed to participate in a clinical research study evaluating Mobile Application Intervention and Rivaroxaban for the treatment of Atrial Fibrillation

Attention Deficit/Hyperactivity Disorder (ADHD - Adults)

Northwest Clinical Research Center

A clinical trial to evaluate treatments using EVO for patients with Attention Deficit Disorder With Hyperactivity

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

Northwest Clinical Research Center

A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR®) in Children Ages 4 to Under 6 Years Diagnosed with Attention Deficit-Hyperactivity Disorder (ADHD)

Northwest Clinical Research Center

A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-dose Safety and Efficacy Study of SPD489 Compared with Placebo in Preschool Children Aged 4-5 Years with Attention-deficit/Hyperactivity Disorder

Northwest Clinical Research Center

A randomized, controlled parallel-group, intervention study to assess at-home, game-based digital therapy for treating pediatric patients participants ages 8 to 12 years old with Attention Deficit Hyperactivity Disorder (ADHD)

Autism

Northwest Clinical Research Center

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, 52-WEEK EFFICACY AND SAFETY STUDY OF RO5285119 IN ADULTS WITH AUTISM SPECTRUM DISORDERS (ASD) WITH A 2-YEAR OPEN LABEL EXTENSION

Northwest Clinical Research Center

A PHASE II MULTI-CENTER, RANDOMIZED, DOUBLEBLIND, 24-WEEK, 3-ARM, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RO5285119 IN CHILDREN AND ADOLESCENTS AGE 5-17 WITH AUTISM SPECTRUM DISORDER (ASD)

View More »

Northwest Clinical Research Center Updated

A clinical trial seeking patients for a research study for the treatment of Autism Spectrum Disorder

Bipolar Disorder

Investigative Site 004

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Breast Cancer

Overlake Medical Center

A clinical research study of paclitaxel, Reparixin and placebo for the treatment of Metastatic Breast Cancer, Triple-Negative Breast Cancer

Chronic Back Pain

Northwest Clinical Research Center

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN

Chronic Pain

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

View More »

Research Site

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

Northwest Clinical Research Center Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Complex Regional Pain Syndrome- type 1 (CRPS-I)

Northwest Clinical Research Center

Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

Constipation

Synergy Pharmaceuticals Inc.

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

COPD (Chronic Obstructive Pulmonary Disease)

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Crohn's Disease

Research Site

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Depression

MMG New

Does Your Child Have Depression?

View More »

Research Site

A clinical trial to evaluate treatments using AXS-05 and Bupropion for patients with Treatment Resistant Major Depressive Disorder

Forest Investigative Site 001

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Investigative Site 001

A clinical research study of Vilazodone for the treatment of Major Depressive Disorder

Investigative Site 004

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

NorthWest Clinical Research Center Updated

Patients are needed to participate in a clinical research study of Rapastinel to evaluate Depressive Disorder, Major

NorthWest Clinical Research Center

A clinical trial to evaluate treatments using Rapastinel and Placebo for patients with Depressive Disorder, Major

Northwest Clinical Research Center Updated

A Phase 3 clinical study for patients with Major Depressive Disorder (MDD)

NorthWest Clinical Research Center Updated

Patients are needed to participate in a clinical research study of Rapastinel and Placebo-matching Rapastinel to evaluate Depressive Disorder, Major

Depression (Adolescent)

MMG New

Does Your Child Have Depression?

Northwest Clinical Research Center

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder

Depression (Major/Severe)

MMG New

Does Your Child Have Depression?

Depression (Pediatric)

Northwest Clinical Research Center

A Multicenter, Double-blind, Placebo- and Active-Controlled Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder

Depression (Treatment-Resistant)

Northwest Clinical Research Center

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Northwest Clinical Research Center

A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder

Diabetes (Pediatric)

Northwest Clinical Research Center

A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial with a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg, and Saxagliptin 2.5 and 5 mg in Pediatric Patients with Type 2 Diabetes Mellitus who are between 10 and below 18 years of age

Northwest Clinical Research Center

A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Northwest Clinical Research Center

A clinical research study of Dulaglutide and Placebo for the treatment of Type 2 Diabetes

Dyskinesias

Neurocrine Clinical Site

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Dyslipidemia

Research Site Updated

A clinical research study for the treatment of Medical Conditions to be Studied, Dyslipidemia or ASCVD Management

Glaucoma

Specialty Eye Care

A clinical trial to evaluate treatments using Glaucoma Surgery and InnFocus MicroShunt for patients with Primary Open Angle Glaucoma

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Heart Attack (Myocardial Infarction)

Novartis Investigative Site

A Phase 3 clinical study for patients with Acute Myocardial Infarction

Hemodialysis

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Hernia

Overlake Hospital

A clinical study for patients with Hernia, Ventral or Incisional Hernia

High Blood Pressure (Hypertension)

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Inflammatory Bowel Disease

Research Site

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Kidney Disease

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Lung Disease

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Macular Degeneration

Vitreoretinal Associates of Washington

A Phase 3 clinical study for patients with Geographic Atrophy

Migraine (Adult)

Northwest Clinical Research Center

Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (rimegepant) for the Acute Treatment of Migraine

Northwest Clinical Research Center

A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION

Migraine and Cluster Headaches

Northwest Clinical Research Center

A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION

Northwest Clinical Research Center

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE

Northwest Clinical Research Center

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 with a Long-Term Open-Label Extension in Patients with Chronic Cluster Headache

Northwest Clinical Research Center

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Cluster Headaches

Ocular Hypertension

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Osteoarthritis

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY OF THE LONG-TERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF A DOSE TITRATION REGIMEN FOR THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

Northwest Clinical Research Center

A Randomized, Double-Blind, Placebo-controlled trial to assess the efficacy and safety of AXS-02 (disodium zoledronate tetrahydrate) administered orally to subjects with knee osteoarthritis associated with bone marrow lesions.

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED STUDY TO CONFIRM THE EFFICACY OF AN INTRA- ARTICULAR INJECTION OF AMPION™ IN ADULTS WITH PAIN DUE TO SEVERE OSTEOARTHRITIS OF THE KNEE

View More »

Northwest Clinical Research Center Updated

Patients are needed to participate in a clinical research study of Investigational Medical Product (IMP) administered in parent study to evaluate Osteoarthritis

Northwest Clinical Research Center

A clinical research study of Ampion and Saline for the treatment of Osteoarthritis, Knee, Knee Osteoarthritis, Knee Arthritis or Knee Pain Chronic

Northwest Clinical Research Center Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Northwest Clinical Research Center

A clinical trial to evaluate treatments using Placebo, Tanezumab 2.5 mg and Tanezumab 2.5mg/5mg for patients with Osteoarthritis, Knee or Osteoarthritis, Hip

Polyps

Investigational Site Number 8400010

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Postherpetic Neuralgia

Northwest Clinical Research Center

A double-blind, placebo-controlled, randomized dose ranging trial to determine the safety and efficacy of three dose levels of EMA401 in reducing 24-hour average pain intensity score in patients with post-herpetic neuralgia (EMPHENE)

Post-Partum Depression

Northwest Clinical Research Center

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF SAGE-217 IN THE TREATMENT OF ADULT FEMALE SUBJECTS WITH SEVERE POSTPARTUM DEPRESSION

Schizophrenia and Schizoaffective Disorders

Northwest Clinical Research Center

A phase II randomised, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 425809 once daily over 12 week treatment period in patients with Schizophrenia

Northwest Clinical Research Center

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, 52-WEEK EFFICACY AND SAFETY STUDY OF RO5285119 IN ADULTS WITH AUTISM SPECTRUM DISORDERS (ASD) WITH A 2-YEAR OPEN LABEL EXTENSION

Northwest Clinical Research Center

A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults with Schizophrenia

View More »

Alkermes Investigational Site

Patients are needed to participate in a clinical research study of ALKS 3831 and Olanzapine to evaluate Schizophrenia

Tardive Dyskinesia

Northwest Clinical Research Center

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

View More »

Neurocrine Clinical Site

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Ulcerative Colitis

Northwest Gastroenterology Associates

A Phase 3 clinical study for patients with Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial to evaluate treatments using etrolizumab for patients with Ulcerative Colitis

Northwest Gastroenterology Associates /ID# 163629 Updated

A Phase 2 clinical study for patients with Ulcerative Colitis (UC)

Ulcers

Northwest Gastroenterology Associates

A Phase 3 clinical study for patients with Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial to evaluate treatments using etrolizumab for patients with Ulcerative Colitis

Northwest Gastroenterology Associates /ID# 163629 Updated

A Phase 2 clinical study for patients with Ulcerative Colitis (UC)